Updating results
150 results for kidney cancer Sort: Relevance | Date
Everything NICE has said on renal (kidney) cancer in an interactive flowchart
Evidence-based recommendations on pazopanib (Votrient) for the first-line treatment of advanced renal cell carcinoma (RCC/kidney cancer)
Evidence-based recommendations on axitinib (Inlyta) for treating advanced renal cell carcinoma (RCC) (kidney cancer) when prior systemic treatment has failed
Evidence-based recommendations on percutaneous cryotherapy for renal (kidney) cancer
Evidence-based recommendations on irreversible electroporation (IRE) for treating renal (kidney) cancer
Evidence-based recommendations on percutaneous radiofrequency ablation for treating renal (kidney) cancer
Evidence-based recommendations on laparoscopic cryotherapy (keyhole surgery to destroy cancer cells by freezing) for treating renal (kidney) cancer
Evidence-based recommendations on everolimus (Afinitor) for advanced renal cell carcinoma (kidney cancer) after previous treatment
Evidence-based recommendations on cabozantinib (Cabometyx) for previously treated advance renal cell carcinoma (kidney cancer) in adults
Evidence-based recommendations on lenvatinib (Kisplyx) with everolimus for previously treated advanced renal cell carcinoma (kidney cancer) in adults
Evidence-based recommendations on laparoscopic nephrectomy (including nephroureterectomy; keyhole surgery to remove a kidney)
Evidence-based recommendations on sunitinib (Sutent) for the first-line treatment of advanced and/or metastatic renal cell carcinoma
Evidence-based recommendations on nivolumab (Opdivo) for previously treated advanced renal cell carcinoma (RCC/kidney cancer) in adults
Evidence-based recommendations on tivozanib (Fotivda) for previously untreated advanced renal cell carcinoma (RCC/kidney cancer) in adults
In development [GID-TA10189] Expected publication date: TBC
Evidence-based recommendations on evacizumab (Avastin), soradenib (Nexavar), sunitinib (Sutent) and temsirolimus (Torisel) for renal cell carcinoma
Evidence-based recommendations on the prevention, detection and management of acute kidney injury (AKI)
Evidence-based statements to deliver quality improvements in the prevention, detection and management of non-traumatic acute kidney injury (AKI)
Evidence-based recommendations on assessing and managing urinary incontinence (lower urinary tract dysfunction) in people with a neurological condition
Everything NICE has said on kidney (renal) conditions in an interactive flowchart
Evidence-based recommendations on strong opioids for pain relief for adults having palliative (end of life) care
Evidence-based recommendations on the care and management of type 2 diabetes in adults
Evidence-based recommendations on diagnosing and managing venous thromboembolic diseases (VTE, deep vein thrombosis, DVT, blood clots) in adults
Evidence-based statements to deliver quality improvements in the management of renal replacement therapy services for adults with kidney failure
Evidence-based recommendations on anaemia management in people with chronic kidney disease (CKD).
Evidence-based recommendations on preventing and managing neutropenic sepsis in people with cancer who are having anticancer treatment
Evidence-based recommendations on single-port laparoscopic nephrectomy (‘keyhole’ surgery) to remove a kidney
Evidence-based recommendations on laparoscopic partial nephrectomy (keyhole surgery to remove kidney tumours)
Evidence-based recommendations on immunosuppressive therapies for preventing kidney rejection in adults
Evidence-based recommendations on managing intravenous (IV) fluids for children and young people under 16 years.
Evidence-based recommendations on the diagnosing and managing of myeloma in people aged 16 and over.
Evidence-based recommendations on immunosuppressive therapy for kidney transplant in children and young people
Everything NICE has said on urogenital conditions in an interactive flowchart
Evidence-based recommendations on machine perfusion systems and cold static storage of kidneys from deceased donors
Evidence-based recommendations on pembrolizumab (Keytruda) for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable
Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart
Evidence-based recommendations on irreversible electroporation (IRE) for treating liver metastases (secondary cancers)
Evidence-based recommendations on diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over
Evidence-based recommendations on atezolizumab (Tecentriq) for untreated PD-L1-positive locally advanced or metastatic urothelial carcinoma in adults
Evidence-based recommendations on pembrolizumab (Keytruda) for locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
Evidence-based recommendations on the recognition, diagnosis and early management of sepsis (blood poisoning / septicaemia) in all populations
dialysis or die. One patient in 5 has aHUS affecting organs other than the kidneys, most commonly the brain or heart. 2.2 aHUS can occur...
Evidence-recommendations on erythropoiesis-stimulation agents (epoetin alfa, beta, theta and zeta and darbepoetin alfa) for anaemia in people with cancer..
Evidence-based recommendations on managing acute and chronic pancreatitis in children, young people and adults
Evidence-based recommendations on non-alcoholic fatty liver disease (NAFLD) for adults, young people and children who have advanced liver fibrosis
Evidence-based recommendations on minimally invasive (keyhole) video-assisted parathyroidectomy to remove abnormal parathyroid glands
Evidence-based statements to deliver quality improvements in encouraging physical activity in people of all ages who are in contact with the NHS
Evidence-based recommendations on irreversible electroporation (IRE) for treating primary lung cancer and metastases in the lung
Evidence-based recommendations on pemetrexed (Alimta) for treating malignant pleural mesothelioma (cancer)
Evidence-based recommendations on irreversible electroporation (IRE) for treating primary liver cancer